drugset / Trial / NCT07043270
24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this research is to study the effects and safety of alternating neoadjuvant chemotherapy on borderline resectable pancreatic cancer.
Timeline
- Start
- 2025-09-29
- Primary completion
- 2028-07-01
- Completion
- 2029-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | — | — |
| Subject | Nab-paclitaxel | Small molecule | — | — |